Author:
Odds F. C.,Bossche H. Vanden
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference7 articles.
1. Heykants, J., Van Peer, A., Van de Velde, V., Van Rooy, P., Meuldermans, W., Lavrijsen, K. et al. (1989). The clinical pharmacokinetics of itraconazole: an overview. Mycoses32, Suppl. 1, 67–87.
2. Hostetler, J. S., Heykants, J., Clemons, K. V., Woestenborghs, R., Hanson, L. H. & Stevens, D. A. (1993). Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations. Antimicrobial Agents and Chemotherapy37, 2224–7.
3. Mikami, Y., Sakamoto, T., Yazawa, K., Gonoi, T., Ueno, Y. & Hasegawa, S. (1994). Comparison of in vitro antifungal activity of itraconazole and hydroxy-itraconazole by colorimetric MTT assay. Mycoses37, 27–33.
4. Odds, F. C., Vranckx, L. & Woestenborghs, F. (1995). Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrobial Agents and Chemotherapy39, 2051–60.
5. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts—Approved Standard M27-A. NCCLS, Wayne, PA.
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献